42 Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit pathogens directed to aquatic organism; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit pathogens directed to aquatic organism grown in aquaculture; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms grown in aquaculture; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms grown in aquaculture; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit bacterial quorum-sensing Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit bacterial quorum-sensing; Research and development of new biological products for therapeutic use to prevent or treat aquatic diseases; Research and development of new biological products for therapeutic use to prevent or treat diseases affecting animals grown in aquaculture
Trademark: 88225561
